Optimization of experimental conditions to study intestinal transport of the antiviral agent UC-781

S. Deferme; J. Van Gelder; Stefan Buck; Guy Van den Mooter; Jan Balzarini; Lieve Naesens; De Clercq Erik; Renaat Kinget; Patrick Augustijns

Related publications

Article2002

Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781

S. Deferme, J. Van Gelder, F. Ingels, Guy Van den Mooter, Stijn De Buck, Jan Balzarini, Lieve Naesens, De Clercq Erik, Renaat Kinget, Patrick Augustijns

Article1998

Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent

Jan Balzarini, Lieve Naesens, Eric Verbeken, Marie Laga, Lut Van Damme, Michael A. Parniak, Lieve Van Mellaert, Jozef Anné, De Clercq Erik

Article1998

The thiocarboxanilide UC-781 is a potential virucidal drug

Jan Balzarini, Lieve Naesens, Eric Verbeken, M. Laga, L. Van Damme, M Verstraeten, Lieve Van Mellaert, Jozef Anné, De Clercq Erik

Article1997

In vitro studies of the intestinal metabolism of ester prodrugs of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine

Pieter Annaert, G. Gosselin, Alain Pompon, J.‐L. IMBACH, L. Naessens, De Clercq Erik, Renaat Kinget, Patrick Augustijns

Article2002

Intestinal absorption enhancement of the antiviral ester prodrug Tenofovir DF

J. Van Gelder, De Clercq Erik, Patrick Augustijns